Search Results - "Cobo, María Yera"

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice by González‐López, Tomás J., Alvarez‐Román, María T., Pascual, Cristina, Sánchez‐González, Blanca, Fernández‐Fuentes, Fernando, Pérez‐Rus, Gloria, Hernández‐Rivas, José A., Bernat, Silvia, Bastida, José M., Martínez‐Badas, María P., Martínez‐Robles, Violeta, Soto, Inmaculada, Olivera, Pavel, Bolaños, Estefanía, Alonso, Rafael, Entrena, Laura, Gómez‐Nuñez, Marta, Alonso, Arancha, Yera Cobo, María, Caparrós, Isabel, Tenorio, María, Arrieta‐Cerdán, Esther, Lopez‐Ansoar, Elsa, García‐Frade, Javier, González‐Porras, José R.

“…Summary Eltrombopag is a second‐line treatment in primary immune thrombocytopenia (ITP). However, its role in secondary ITP is unknown. We evaluated the…”
Get full text

Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia by Mingot-Castellano, María E, Caparrós, Isabel S, Fernández, Fernando, Perera-Alvarez, María del Mar, Jimenez-Bárcenas, Reyes, Casaus García, Alberto, González-Silva, Manuel, Yera-Cobo, María, Nieto-Hernandez, María M, Rodríguez-Fernandez, María J, Díaz-Canales, Dana

“…Thrombopoietin receptor agonist (TPO-RAs) have demonstrated good efficacy and tolerance in clinical trials in refractory chronic primary immune…”
Get full text

P1614: TAPERING SCHEME AND SUSTAINED RESPONSE IN PATIENTS WITH ITP TREATED WITH FOSTAMATINIB by Mingot‐Castellano, María Eva, Gabaldon, Gloria García‐Donas, Campos‐Álvarez, Rosa María, Pedrote‐Amador, Begoña, Navarro, Josefa Luis, Cobo, María Yera, Carrasco, Gloria Moreno, Jimenez‐Bárcenas, Reyes

Get full text

Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study by Jiménez‐Bárcenas, Reyes, García‐Donas‐Gabaldón, Gloria, Campos‐Álvarez, Rosa María, Fernández‐Sánchez de Mora, María Carmen, Luis‐Navarro, Josefa, Domínguez‐Rodríguez, Juan Francisco, Nieto‐Hernández, María del Mar, Sánchez‐Bazán, Irene, Yera‐Cobo, Maria, Cardesa‐Cabrera, Rocio, Jiménez‐Gonzalo, Francisco José, Ruiz‐Cobo, María Antonia, Caparrós‐Miranda, Isabel, Entrena‐Ureña, Laura, Fernández Jiménez, Dolores, Díaz‐Canales, Dana, Moreno‐Carrasco, Gloria, Calderón‐Cabrera, Cristina, Núñez‐Vázquez, Ramiro José, Pedrote‐Amador, Begoña, Mingot‐Castellano, María Eva

“…Summary Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase…”
Get full text

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia by González‐López, Tomás José, Sánchez‐González, Blanca, Jarque, Isidro, Bernat, Silvia, Fernández‐Fuertes, Fernando, Caparrós, Isabel, Soto, Inmaculada, Fernández‐Rodríguez, Angeles, Bolaños, Estefanía, Pérez‐Rus, Gloria, Pascual, Cristina, Hernández‐Rivas, José Angel, López‐Ansoar, Elsa, Gómez‐Nuñez, Marta, Martínez‐Robles, Violeta, Olivera, Pavel, Yera Cobo, Maria, Peñarrubia, María Jesús, Fernández‐Miñano, Carmen, Cabo, Erik, Martínez Badas, María Paz, Perdomo, Germán, García‐Frade, Luis Javier

“…Background Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality…”
Get full text

Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice by González-López, Tomás José, Alvarez-Roman, María Teresa, Pascual, Cristina, Sánchez-González, Blanca, Fernández-Fuentes, Fernando, Pérez-Rus, Gloria, Hernández-Rivas, José Angel, Bernat, Silvia, Cortés, Montserrat, Bastida, José María, Martínez-Robles, Violeta, Fernández-Rodríguez, Angeles, Olivera, Pavel, Bolaños, Estefanía, Alonso, Rafael, Entrena, Laura, Gómez-Nuñez, Marta, Bermejo, Nuria, Martínez-Badas, María Paz, Peñarrubia, María Jesús, Alonso, Arancha, Soto, Inmaculada, Yera Cobo, María, Casaus, Alberto, Caparrós, Isabel, Perera, María, Jiménez Bárcenas, Reyes, Heras, Cecilia, Calbacho, María, Tenorio, Maria, Luaña, Armando, Lopez-Ansoar, Elsa, Hermida, Gerardo, García-Frade, Javier, González-Porras, José Ramón, Sanz, Miguel A.

“…Background: Eltrombopag is an oral thrombopoietin receptor agonist (TPO-RA) drug approved in primary chronic ITP. Lack of clinical trials in secondary ITP…”
Get full text